Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evaxion A/S - American Depositary Share (NQ:EVAX)

2.750 -0.300 (-9.84%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evaxion A/S - American Depositary Share

< Previous 1 2 3 4 5 6 7 8 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented
From Evaxion Biotech
Via GlobeNewswire
Why Are Evaxion Biotech Shares Trading Higher Today
 
Via Benzinga
Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From Evaxion Biotech
Via GlobeNewswire
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Is Cancer Immunotherapy Focused Evaxion Biotech Stock Trading Higher Today?
Evaxion Biotech A/S (NASDAQ: EVAX) collaborated with Afrigen Biologics to develop a prophylactic vaccine based on Evaxion's EDEN-discovered  
Via Benzinga
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company
From Evaxion Biotech
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day off with a breakdown of the biggest pre-market stock movers worth watching on Tuesday morning! 
Via InvestorPlace
Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development
From Evaxion Biotech
Via GlobeNewswire
Evaxion announces Executive Management Changes to strengthen the AI-strategy
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
From Evaxion Biotech
Via GlobeNewswire
Evaxion announces financing commitments totaling up to USD 20 million with Negma Group
From Evaxion Biotech
Via GlobeNewswire
Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Gainers Forza X1, Inc. (NASDAQ: FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!' 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
From Evaxion Biotech
Via GlobeNewswire
Evaxion Announces Business Update and First Quarter 2023 Financial Results
From Evaxion Biotech
Via GlobeNewswire
Evaxion unveils proprietary genetic adjuvant technology to boost the effect of DNA and mRNA vaccines
From Evaxion Biotech
Via GlobeNewswire
Evaxion announces promising clinical Phase 1 data for its personalized cancer vaccine EVX-01
From Evaxion Biotech
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.